Found 28 matching trials
Immediate Effects of Lucentis® in Conjunction With Photodynamic Therapy With Visudyne® in Exudative AMD(IECOMB) PHASE2 This study is an evaluation of the short term effects on CNV perfusion of a...
Show More Location
Klinik und Poliklinik fuer Augenheilkunde, Inselspital
Learn More & Join Trial
Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD) PHASE2 This study will evaluate the effect of combination therapy with verteporfin...
Show More Location
Novartis Investigative site
Learn More & Join Trial
Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration PHASE4 The purpose of the investigators study is to look at the visual outcomes of...
Show More Location
The Royal Victoria Hospital and the Montreal Retinal Institute
Learn More & Join Trial
Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-based Retreatment PHASE4 This is a one-year, randomized, single-center open-label pilot study of the...
Show More Location
Illinois Retina Associates
Learn More & Join Trial
Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia PHASE1 To demonstrate the efficacy of ranibizumab in combination with reduced-flue...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration PHASE3 This is a phase III, multicenter, randomized, double-masked, active treatme...
Show More Location
Retina Centers, P.C.
Learn More & Join Trial
Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization PHASE2 The purpose of this study is to compare the efficacy of photodynamic therap...
Show More Location
Centro Medico Isemmym
Learn More & Join Trial
Ranibizumab and the Risk of Arterial Thromboembolic Events PHASE4 The investigators assume that ranibizumab might be dangerous in patients wi...
Show More Location
De Haar Research Foundation
Learn More & Join Trial
Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration PHASE4 In this pilot study the researchers will evaluate the safety and efficacy o...
Show More Location
Eagle Mountain Vision
Learn More & Join Trial
Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy PHASE4 Study the effectiveness of the treatment detachment of retinal pigment epit...
Show More Location
Universidade Federal de São Paulo - Escola Paulista de Medicina
Learn More & Join Trial